Literature DB >> 3401589

Autoantibody against erythrocyte protein 4.1 in a patient with autoimmune hemolytic anemia.

H Wakui1, H Imai, R Kobayashi, H Itoh, T Notoya, K Yoshida, Y Nakamoto, A B Miura.   

Abstract

We observed the presence of a new autoantibody, anti-erythrocyte protein 4.1, in a patient with autoimmune hemolytic anemia (AIHA). Western blotting analysis revealed that IgG from the patient's plasma reacted with erythrocyte protein 4.1. However, among other patients with hemolytic diseases (six having AIHA and three each having either hereditary spherocytosis, elliptocytosis, or lead poisoning) as well as among control subjects, no antibody activity to protein 4.1 was observed. In addition to the anti-protein 4.1 antibody, two different kinds of anti-erythrocyte antibodies were detected by conventional serological studies in this patient. One of them was an anti-Ena-like antibody in the eluate from the patient's erythrocytes, while another was the anti-S-specific antibody in the plasma. An elution study and an absorption study using S antigen-positive erythrocytes demonstrated that the anti-protein 4.1 antibody differed from both the anti-Ena-like antibody and the anti-S antibody. Familial analysis of the patient revealed the same antibody in her brother, who did not have hemolytic anemia. These results demonstrate that anti-protein 4.1 antibody is considered to be included in the spectrum of anti-cytoskeleton autoantibodies, which have been observed in patients having increased cell lysis as well as in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3401589

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

2.  Autoimmune basal ganglia encephalitis with hemolytic anemia.

Authors:  Ralph Werner; Benedikt Lohr; Peter Lodemann; Jens Marcus Chemnitz; Johannes C Woehrle
Journal:  Ann Hematol       Date:  2022-04-21       Impact factor: 4.030

3.  Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies.

Authors:  J P Leddy; J L Falany; G E Kissel; S T Passador; S I Rosenfeld
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

4.  Specific antibody responses against membrane proteins of erythrocytes infected by Plasmodium falciparum of individuals briefly exposed to malaria.

Authors:  Albin Fontaine; Matthieu Pophillat; Stéphanie Bourdon; Claude Villard; Maya Belghazi; Patrick Fourquet; Claude Durand; Didier Lefranc; Christophe Rogier; Thierry Fusai; Lionel Almeras
Journal:  Malar J       Date:  2010-10-11       Impact factor: 2.979

Review 5.  The pathophysiology of extracellular hemoglobin associated with enhanced oxidative reactions.

Authors:  Joseph M Rifkind; Joy G Mohanty; Enika Nagababu
Journal:  Front Physiol       Date:  2015-01-14       Impact factor: 4.566

6.  A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins.

Authors:  Wei Zhang; Jung-Hyun Rho; Michael W Roehrl; Michael H Roehrl; Julia Y Wang
Journal:  PLoS One       Date:  2019-06-25       Impact factor: 3.240

7.  Complications of Evans' syndrome in an infant with hereditary spherocytosis: a case report.

Authors:  Hideki Yoshida; Hiroyuki Ishida; Takao Yoshihara; Takashi Oyamada; Masataka Kuwana; Toshihiko Imamura; Akira Morimoto
Journal:  J Hematol Oncol       Date:  2009-09-10       Impact factor: 17.388

8.  Autoimmune hemolytic anemia occurred prior to evident nephropathy in a patient with chronic hepatitis C virus infection: case report.

Authors:  Isao Ohsawa; Yuki Uehara; Sumiko Hashimoto; Morito Endo; Takayuki Fujita; Hiroyuki Ohi
Journal:  BMC Nephrol       Date:  2003-08-29       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.